ReviewInternational journal of biomaterials2025
Protein-Based Silver Nanoparticles: Synthesis, Characterization, Administration, and Nanomedicine Applications.
Review in International journal of biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Biogenic Zinc Oxide Nanoparticles for Skin Disorders: Mechanistic Insights, Translational Challenges, and Future Prospects.Biological trace element research · 2026Review
- Green Synthesis of Bergamot Solid Waste-Based Silver Nanoparticles: Optimization Process for Agriculture Use.Molecules (Basel, Switzerland) · 2026Article
- Electroactive Proteinoid-Quantum Dot Systems.Small science · 2025Article
- Artificial neural network optimized green synthesis of cysteine-conjugated silver nanoparticles for antibacterial activity against staphylococcus nepalensis to combat cystitis.Antonie van Leeuwenhoek · 2025Article
- Engineered BSA nanoparticles: Synthesis, drug loading, and advanced characterization.Biology methods & protocols · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology has emerged as a transformative field in recent years, greatly impacting medicine and healthcare with innovative solutions for complex diseases. Among these advancements, protein-based metal nanoparticles have shown exceptional promise in treating chronic illnesses, owing to their high biocompatibility, biodegradability, customizable surface properties, and precise drug delivery capabilities. Recent studies have highlighted advancements in targeting efficiency and controlled release, alongside the ability of protein-based metal nanoparticles to bypass the first-pass metabolism, enhancing bioavailability through novel administration routes. Cutting-edge research has also focused on functionalizing protein nanostructures with therapeutic metal ions, particularly silver, with a longstanding antimicrobial and anti-inflammatory history. New combinations of silver with protein-based nanoparticles are now showing significant potential in managing chronic and life-threatening conditions. This review provides a comprehensive overview of the latest synthesis methods, toxicity assessments, therapeutic applications, administration pathways, and advanced characterization techniques for protein-based silver nanoparticles, addressing the evolving landscape of nanomedicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.